Pretreatment with ondansetron blunts plasma vasopressin increases associated with morphine administration in ferrets

Anesthesia and Analgesia

Volumn 101, Issue 4, 2005, Pages 1029-1033

  Wilkens, Eric P ^a   Yates, Bill J ^b  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; KETAMINE; KETOPROFEN; MORPHINE SULFATE; ONDANSETRON; XYLAZINE;

ANALYSIS OF VARIANCE; ANESTHETIC RECOVERY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FERRET; KRUSKAL WALLIS TEST; MALE; NONHUMAN; POSTOPERATIVE NAUSEA AND VOMITING; PREMEDICATION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RANK SUM TEST; VASOPRESSIN BLOOD LEVEL;

EID: 25644443884     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000166954.61498.2c     Document Type: Article

References (25)

1. Kapur P. The big "little problem" [editorial]. Anesth Analg 1991; 73:243-5.
2. Camu F, Lauwers MH, Verbessem D. Incidence and aetiology of post-operative nausea and vomiting. Eur J Anaesthesiol 1992; 9(Suppl):25-33.
3. Watcha MF, Smith I. Cost-effectiveness analysis of antiemetic therapy for ambulatory surgery. J Clin Anesth 1994;6:370-7.
4. Fujii Y, Tanaka H, Somekawa Y. Granisetron, droperidol, and metoclopramide for the treatment of established postoperative nausea and vomiting in women undergoing gynecologic surgery. Am J Obstet Gynecol 2000;182:13-16.
5. Wittels B, Faure EA, Chavez R. et al. Effective analgesia after bilateral tubal ligation. Anesth Analg 1998;87:619-23.
6. Fujii Y, Toyooka H, Tanaka H. Prevention of postoperative nausea and vomiting in female patients during menstruation: comparison of droperidol, metoclopramide and granisetron. Br J Anaesth 1998;80:248-9.
7. Polati E, Verlato G, Finco G. et al. Ondansetron versus metoclopramide in the treatment of postoperative nausea and vomiting. Anesth Analg 1997;85:395-9.
8. Raphael JH, Norton AC. Antiemetic efficacy of prophylactic ondansetron in laparoscopic surgery: randomized, double-blind comparison with metoclopramide. Br J Anaesth 1993;71:845-8.
9. Alon E, Himmelseher S. Ondansetron in the treatment of postoperative vomiting: a randomized, double-blind comparison with droperidol and metoclopramide. Anesth Analg 1992;75:561-5.
10. Billig I, Yates BJ, Rinaman L. Plasma hormone levels and central cFos expression in ferrets after systemic administration of cholecystokinin. Am J Physiol Regul Integr Comp Physiol 2001;281: R1243-55.
11. Koch KL, Summy-Long J, Bingaman S. et al. Vasopressin and oxytocin responses to illusory self-motion and nausea in man. J Clin Endocrinol Metab 1990;71:1269-75.
12. Thompson PI, Bingham S, Andrews PL. et al. Morphine-6-glucuronide: a metabolite of morphine with greater emetic potency than morphine in the ferret. Br J Pharmacol 1992;106:3-8.
13. D'Allens H, Aubert B, Bons J, Pappo M. Ondansetron: a specific 5-HT3 serotonin receptor inhibitor, a new anti-emetic in oncology. Bull du Cancer 1991;78:1139-46.
14. Bermudez J, Boyle EA, Miner WD, Sanger GJ. The anti-emetic potential of the 5-hydroxytrypamine3 receptor antagonist BRL 43694. Br J Cancer 1988;58:644-50.
15. Kirchner V, Aapro M, Alberto P, et al. Early clinical trial of MDL 73.147 EF: a new 5-HT3-receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting. Ann Oncol 1993;4:481-4.
16. Parrott RF, Forsling ML. Central and peripheral doses of cholecystokinin that inhibit feeding in pigs also stimulate vasopressin and cortisol release. Exp Physiol 1991;76:525-31.
17. Caras SD, Soykan I, Beverly V, et al. The effect of intravenous vasopressin on gastric myoelectrical activity in human subjects. Neurogastroenterol Motil 1997;9:151-63.
18. Kim MS, Chey WD, Owyang C, Hasler WL. Role of plasma vasopressin as a mediator of nausea and gastric slow wave dysrhythmias in motion sickness. Am J Physiol 1997;272(4 Pt 1):G853-62.
19. Barreca T, Corsini G, Cataldi A, et al. Effect of the 5-HT3 receptor antagonist ondansetron on plasma AVP secretion: a study in cancer patients. Biomed Pharmacother 1996;50:512-4.
20. Friess U, Rascher W, Ritz E, Gross P. Failure of arginine vasopressin and other pressor hormones to increase in severe recurrent dialysis hypotension. Nephrol Dial Transplant 1995;10: 1421-7.
21. Page SR, Peterson DB, Crosby SR, et al. The responses of arginine vasopressin and adrenocorticotrophin to nausea induced by ipecacuanha. Clin Endocrinol 1990;33:761-70.
22. Xu LH, Koch KL, Summy-Long J, et al. Hypothalamic and gastric myoelectrical responses during vection-induced nausea in healthy Chinese subjects. Am J Physiol 1993;265(4 Pt 1):E78-84.
23. Edwards CM, Carmichael J, Baylis PH, Harris AL. Arginine vasopressin: a mediator of chemotherapy induced emesis? Br J Cancer 1989;59(3):467-70.
24. Nussey SS, Hawthorn J, Page SR, et al. Responses of plasma oxytocin and arginine vasopressin to nausea induced by apomorphine and ipecacuanha. Clin Endocrinol 1988;28:297-304.
25. Ebenezer I, Thornton SN, Parrot RF. Anterior and posterior pituitary hormone release induced in sheep by cholecystokinin. Am J Physiol 1989;256:R1355-7.